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ABSTRACT
Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder caused by a mutation in the
FBN1 gene, which encodes for the extracellular matrix protein fibrillin-1. The MFS clinical manifestations that
lead to morbidity and mortality are primarily those involving aortic disease, such as aneurysmal dilation,
aortic regurgitation, and aortic dissection. Despite the fact that 60-80% of adults with MFS have some degree
of aortic disease, carotid artery aneurysms are rare and usually represent extensions of aortic dissections.1 We
report a 70-year-old female with a history of ectopia lentis and a family history of MFS who presented to the
emergency department with epistaxis and anemia. An arteriogram revealed an incidental finding of bilateral
carotid artery aneurysms, a rare phenomenon even in the presence of connective tissue disease. Review of the
literature revealed very little data on the clinical presentation, treatment, and outcome of MFS patients with
extracranial carotid artery aneurysms (ECAAs). We discuss presentation, etiology, and management options
reported for these rare occurrences.
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INTRODUCTION

CASE REPORT

Extracranial carotid artery aneurysms (ECAAs) are an
uncommon pathology, and bilateral ECAAs represent
6-12% of carotid artery aneurysms.2-5 There can be
significant diversity in the presentation of ECAAs;
however, due to the frequent use of imaging in modern medicine, their discovery as an incidental finding
in asymptomatic patients is increasing. The etiology
of ECAAs is quite diverse and includes connective
tissue diseases, such as Marfan syndrome (MFS),
Ehlers-Danlos syndrome, osteogenesis imperfecta,
and pseudoxanthoma elasticum.6 MFS is caused by
a mutation in the FBN1 gene that encodes for the
extracellular matrix protein fibrillin-1 and has an
autosomal dominant inheritance pattern. Despite the
link between connective tissue disease and ECAAs,
the incidence of ECAAs in MFS patients is actually
quite low.7,8 Furthermore, there is limited research
on best-practice management for these patients. We
present a case of asymptomatic bilateral ECAAs in a
patient who had a history suggestive of MFS and was
managed with conservative therapy.

A 70-year-old female presented to the emergency
department with uncontrolled epistaxis. Her past
medical history included hypertension, hyperlipidemia, hypothyroidism, type 2 diabetes mellitus,
and ectopia lentis. Upon arrival, a complete blood
count revealed a hemoglobin (Hgb) of 10.8 g/dL. The
epistaxis initially responded to sterile tissue packing;
however, she subsequently developed two recurrent
episodes of epistaxis accompanied by a decrease in
her Hgb to 9.2 g/dL. Cauterization of the right internal
maxillary artery failed to control the bleeding; therefore, an arterial embolization was planned. Computed
tomography angiography imaging was performed
during arterial embolization, yielding an unexpected
finding of bilateral ECAAs (Figure 1). The epistaxis
resolved after embolization.
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Given the patient’s history of ectopia lentis and a positive family history, MFS was most likely the underlying etiology of her vascular abnormalities. Although
she had no other physical exam findings indicative
of MFS, her positive family history along with her
ectopia lentis qualify for a diagnosis of MFS under the
Revised Ghent criterion.9 The patient remains asymp-
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FIGURE 1. (Left) Computed tomography angiography shows 9.3- and 9-mm right internal carotid
artery aneurysms in the mid and distal C1 segments, respectively, and a 9.7-mm left internal carotid
artery aneurysm. (Right) This computed tomography angiography shows the C1 segment of the
internal carotid artery at the aneurysm level with no evidence of dissection.

tomatic, and subsequent follow-up arteriograms at
yearly intervals revealed no significant growth in the
aneurysms over 2 years. There have been no additional aneurysms discovered in the patient.
DISCUSSION
ECAAs are exceedingly rare in patients with MFS, and
to the best of our knowledge, only 10 total cases have
been reported in the literature.8 In general, patients
who develop ECAAs can present with a pulsatile
mass, cerebral ischemic event, cranial nerve deficit,
infection, dysphagia, tinnitus, bruit, hemorrhage,
hoarseness, tracheal obstruction, dizziness, or without symptoms. However, in patients with MFS, the
most common presentation is either asymptomatic
or as a pulsatile cervical mass.7,10 The pathogenesis
by which MFS leads to aneurysmal dilation involves
the loss in functionality of the protein fibrillin-1. This
extracellular matrix glycoprotein is encoded by the
FBN1 gene, which undergoes mutations in patients
with MFS. Malfunction of fibrillin-1 causes a loss in
elasticity of a patient’s arterial wall, leading to a susceptibility to aneurysms.11 The histology of aneurysms
in patients with connective tissue disease differ from
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those formed secondary to atherosclerotic disease,
with the former consisting of cystic medial necrosis, loss of elastic fibers, and an increase in mucoid
material.1,7
The treatment options for ECAAs include surgical or
endovascular repair or conservative management,
but there has yet to be a clear consensus on the best
therapy.10,12 Surgical or endovascular interventions
are typically recommended for symptomatic ECAAs,
suspected infection, increasing aneurysm size, and
absolute diameters greater than 2 cm. If an ECAA is
to be managed surgically, options include excision
with primary anastomosis, excision with interposition
graft, or extracranial-intracranial bypass.7 Historically,
surgical treatment was by carotid ligation, but this is
no longer common practice, as it is associated with
a stroke risk of 25% and a mortality rate of 20%.5,12,14
In a review by Kraemer and Zhou, complication rates
from open surgery showed an early risk of mortality
ranging from 0 to 7%, perioperative stroke ranging
from 0.7 to 11%, and cranial nerve injury ranging
from 0 to 66%. Cranial nerve injuries included injuries
to facial, vagus, spinal accessory, hypoglossal, and
glossopharyngeal nerves. In spite of the risks, open
surgery usually resulted in technical success.10,15
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More recently, an endovascular approach has played
an increasing role in the treatment of ECAAs. This
approach consists of embolization of aneurysms with
detachable coils and the use of stents or graft-covered stents.2 A systematic review on endovascular
interventions found procedure success to be greater
than 90% with incidences of stroke of 1.8%, cranial
nerve injury of 0.5%, and overall in-hospital mortality
of 4.1%. The authors concluded that the high success rate and low complication rate for this approach
make it feasible for continued exploration.16 However,
patients with MFS may have anatomical differences,
such as elongated internal carotid arteries, which may
increase the risk for kinking or thrombosis after stent
placement, and therefore, may have worse outcomes
with this kind of intervention.8
Information regarding conservative therapy for
ECAAs is best described by Fankhauser et al.6 Treatments include antiplatelet therapy, anticoagulation
therapy, and serial imaging. Similar to our patient,
most of the patients studied were asymptomatic but
also had prior imaging that revealed the stability of
the aneurysm. The authors demonstrated that treating patients medically resulted in no major morbidity
or mortality related to the aneurysm.
CONCLUSION
ECAAs are an uncommon complication with varying
presentations, etiologies, and management strategies. The recommendations in the literature for
treatment of this pathology vary, and there seems
to be no consensus at this time. While open surgery
usually achieves clinical success, it is not without risk
and may be unnecessary in asymptomatic patients.
Endovascular approaches have been gaining popularity, but anatomical hurdles in MFS patients may
hinder the use of this approach. Conservative follow-up of asymptomatic patients with serial imaging
has the least risk; however, more research is necessary
to determine the threshold for treatment as far as
what constitutes dangerous growth of the aneurysm
and what symptoms should prompt treatment with
surgery or stents rather than antiplatelet agents. The
uncommon presence of bilateral ECAAs only further
complicates the choice of an aggressive management
strategy, given that the risk of morbidity and mortalMARSHALL JOURNAL OF
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ity with procedures on two arteries would likely be
increased. Based on the current available evidence,
patients should be apprised of the risks and benefits
of treatment options and come to a joint decision
with their healthcare provider.
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